[Translation] A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of CU-40101 Liniment in Adult Male Subjects with Androgenetic Alopecia
主要目的:评价CU-40101搽剂在成年男性雄激素性秃发受试者中单剂和多剂局部皮肤涂抹给药的安全性和耐受性。
次要目的:评价CU-40101搽剂在成年男性雄激素性秃发受试者中单剂和多剂局部皮肤涂抹给药的药代动力学(PK)特征。
探索性目的:探索CU-40101搽剂多剂局部皮肤涂抹给药治疗成年男性雄激素性秃发的有效性
[Translation] Primary objective: To evaluate the safety and tolerability of single and multiple topical skin application of CU-40101 liniment in adult male subjects with androgenetic alopecia.
Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of single and multiple topical skin application of CU-40101 liniment in adult male subjects with androgenetic alopecia.
Exploratory objective: To explore the effectiveness of multiple topical skin application of CU-40101 liniment in the treatment of androgenetic alopecia in adult men